Mesothelioma cells: Control vs CD26 knockdown. Homo sapiens
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
CD26 is a prognostic factor in many cancers and implicated as therapeutic target. Knockdown of CD26 on mesothelioma cells H226 and JMN inhibit tumor progression. In order to elucidate CD26-mediated pathway for tumor progression, CD26 was knocked down on H226 and JMN cells, and RNAs from these cells were subjected to Microarray analysis. Overall design: By analyzing microarray data of CD26 knockdown, select candidate molecules, and validate its expression on control and CD26 knocked down cells by qRT-PCR. Then, protein expression will be studied.
创建时间：
2017-06-20
